Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ALKEM LABORATORIES PFIZER/
ALKEM LABORATORIES
 
P/E (TTM) x 38.2 37.5 101.9% View Chart
P/BV x 6.0 6.5 91.6% View Chart
Dividend Yield % 1.7 1.0 164.9%  

Financials

 PFIZER   ALKEM LABORATORIES
EQUITY SHARE DATA
    PFIZER
Mar-23
ALKEM LABORATORIES
Mar-23
PFIZER/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4,6623,625 128.6%   
Low Rs3,4072,835 120.2%   
Sales per share (Unadj.) Rs530.0970.1 54.6%  
Earnings per share (Unadj.) Rs136.484.2 162.0%  
Cash flow per share (Unadj.) Rs159.4110.2 144.7%  
Dividends per share (Unadj.) Rs70.0050.00 140.0%  
Avg Dividend yield %1.71.5 112.1%  
Book value per share (Unadj.) Rs701.0756.4 92.7%  
Shares outstanding (eoy) m45.75119.57 38.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.63.3 228.6%   
Avg P/E ratio x29.638.4 77.1%  
P/CF ratio (eoy) x25.329.3 86.3%  
Price / Book Value ratio x5.84.3 134.8%  
Dividend payout %51.359.4 86.4%   
Avg Mkt Cap Rs m184,576386,207 47.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,31721,314 15.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,248115,993 20.9%  
Other income Rs m1,0112,161 46.8%   
Total revenues Rs m25,258118,153 21.4%   
Gross profit Rs m8,42015,065 55.9%  
Depreciation Rs m1,0553,104 34.0%   
Interest Rs m1351,074 12.6%   
Profit before tax Rs m8,24013,048 63.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,0012,980 67.1%   
Profit after tax Rs m6,23910,068 62.0%  
Gross profit margin %34.713.0 267.4%  
Effective tax rate %24.322.8 106.3%   
Net profit margin %25.78.7 296.4%  
BALANCE SHEET DATA
Current assets Rs m24,93386,064 29.0%   
Current liabilities Rs m6,57437,071 17.7%   
Net working cap to sales %75.742.2 179.3%  
Current ratio x3.82.3 163.4%  
Inventory Days Days9333 286.8%  
Debtors Days Days267 3.4%  
Net fixed assets Rs m13,78037,245 37.0%   
Share capital Rs m458239 191.3%   
"Free" reserves Rs m31,61690,208 35.0%   
Net worth Rs m32,07390,447 35.5%   
Long term debt Rs m00-   
Total assets Rs m39,031124,541 31.3%  
Interest coverage x62.113.2 472.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 66.7%   
Return on assets %16.38.9 182.5%  
Return on equity %19.511.1 174.8%  
Return on capital %26.115.6 167.2%  
Exports to sales %2.814.6 19.4%   
Imports to sales %00-   
Exports (fob) Rs m68816,916 4.1%   
Imports (cif) Rs m8NA-   
Fx inflow Rs m68816,916 4.1%   
Fx outflow Rs m84,190 0.2%   
Net fx Rs m67912,727 5.3%   
CASH FLOW
From Operations Rs m3,55716,825 21.1%  
From Investments Rs m-3611,128 -31.9%  
From Financial Activity Rs m-3,458-17,608 19.6%  
Net Cashflow Rs m-262416 -62.9%  

Share Holding

Indian Promoters % 0.0 56.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 18.2 24.4 74.5%  
FIIs % 3.0 8.5 35.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 43.3 83.4%  
Shareholders   112,456 65,184 172.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs ALKEM LABORATORIES Share Price Performance

Period Pfizer ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -4.80% -1.18% 1.18%
1-Month -8.24% -0.99% -0.75%
1-Year 21.78% 52.26% 61.82%
3-Year CAGR -2.07% 21.70% 18.16%
5-Year CAGR 4.95% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Pfizer, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.